MGNX.NASDAQMacrogenics INC

Form 4: MacroGenics Director William K. Heiden Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Director William K. Heiden reports acquisition and disposal of MacroGenics stock and stock options.

Summary

  • On May 20, 2025, William K. Heiden, a director of MacroGenics Inc., reported transactions involving the company's stock.
  • Heiden acquired 6,500 shares of common stock through the vesting of restricted stock units (RSUs).
  • He also disposed of 6,500 shares of common stock.
  • On May 21, 2025, Heiden acquired 3,750 restricted stock units and 22,000 stock options with an exercise price of $1.49, vesting monthly over one year, expiring on May 21, 2035.
  • Following these transactions, Heiden directly owns 11,000 shares of common stock, 3,750 restricted stock units, and 22,000 stock options.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports transactions. The acquisition of stock options could be seen as slightly positive, but overall, it's a routine filing.

Positives

  • The acquisition of stock options and restricted stock units by a director could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are a routine part of regulatory compliance for publicly traded companies, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

  • The transactions could influence investor sentiment regarding MacroGenics.

Key Dates

DateDescription
05/20/2025Date of common stock acquisition and disposal via RSU vesting.
05/20/2025RSUs vested one day prior to the Issuer's 2025 Annual Meeting of Stockholders held on May 21, 2025.
05/21/2025Date of RSU and stock option acquisition.
05/21/2035Expiration date of the acquired stock options.
05/22/2025Date of Form 4 filing.

Keywords

MacroGenics, MGNX, Director, Stock Options, Restricted Stock Units, Form 4, Insider Trading, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.